With more than a million confirmed cases of COVID-19 in the United States, there is growing concern that low-income communities and racial/ethnic minorities may be disproportionately shouldering the burden of the pandemic. 

Whether or not you are a smoker could condition how the coronavirus affects you. 

Yale researchers will begin a clinical trial at Yale New Haven Hospital to test the effectiveness of a drug called ibudilast (MN-166) for treating acute respiratory distress syndrome (ARDS), a life-threatening lung condition developed by some of the most seriously ill COVID-19 patients.

Strategies that treat households in the broad vicinity of a recent malaria case with anti-malarial drugs, insecticides, or both could significantly reduce malaria in low-transmission settings, a challenge with approaches currently in use, a study led by UT Southwestern scientists suggests.

Over the past few decades, there have been a handful of incidents in which manufacturing processes for making protein drugs became contaminated with viruses at manufacturing plants.

Scientists are using information from NASA’s Earth-observing satellites, on-the-ground sensors and computer-based datasets to study the environmental, economic and societal impacts of the COVID-19 pandemic.

As pollution levels drop worldwide amid stay-at-home orders, researchers consider what this might mean for the future.

Scripps Oceanography climate scientists ponder what episode tells us about global warming.

Scientists detect human waste contamination in the mudslide debris used to enrich Goleta Beach.

Children who experience trauma, abuse, neglect and family dysfunction are at increased risk of having heart disease in their 50s and 60s, according to a new Northwestern Medicine study.